Psychiatric morbidity in narcoleptics on chronic high dose methylphenidate therapy

J Nerv Ment Dis. 1995 Jan;183(1):45-8. doi: 10.1097/00005053-199501000-00009.

Authors

L K Pawluk¹, T D Hurwitz, J L Schluter, C Ullevig, M W Mahowald

Affiliation

¹ Minnesota Regional Sleep Disorders Center, Hennepin County Medical Center, University of Minnesota Medical School, Minneapolis.

PMID: 7807070
DOI: 10.1097/00005053-199501000-00009

No abstract available

MeSH terms

Adult
Causality
Depressive Disorder / chemically induced
Depressive Disorder / diagnosis
Depressive Disorder / epidemiology*
Dose-Response Relationship, Drug
Female
Humans
MMPI
Male
Methylphenidate / administration & dosage*
Methylphenidate / adverse effects
Middle Aged
Narcolepsy / drug therapy*
Personality Inventory
Psychiatric Status Rating Scales
Psychoses, Substance-Induced / diagnosis
Psychoses, Substance-Induced / epidemiology*
Psychoses, Substance-Induced / etiology
Risk Factors

Substances

Methylphenidate